Open AccessLack of clearly defined role for anti-programmed death-(ligand) 1 therapy in epidermal growth factor receptor mutated non-small cell lung cancer
Author(s) -
Aaron Lisberg,
Edward B. Garon
Publication year - 2019
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2019.02.01
Subject(s) - epidermal growth factor receptor , medicine , pembrolizumab , lung cancer , tyrosine kinase , cancer research , oncology , targeted therapy , cancer , receptor , immunotherapy